Dr Kevin Flavin
Kevin was born in 1981 in Waterford City, Ireland. He relocated to Amsterdam, the Netherlands, at the age of nine where he lived for eight years. He returned to Ireland at the age of seventeen, where he attained his BSc in applied chemistry and subsequently his PhD under the supervision of Dr Peter McLoughlin and Dr Helen Hughes at Waterford Institute of Technology.
Kevin's work focused on the production process of montelukast sodium, which is a chiral pharmaceutical generically known as Singular ® , manufactured by Merck, Sharp & Dohme (Irl.) Ltd. for the treatment of asthma. The primary objective of this research was the development of novel polymeric extraction media, which may be utilised in the analytical determination of residual waste solvents and in the preparation of a selective purification medium related to the montelukast sodium production process. The main body of the work was related to the on-line monitoring of environmentally harmful residual waste solvents utilised during the preparation of montelukast sodium. Further work included the preparation of a selective molecularly imprinted polymer phase for the separation of montelukast from its related substances.
Kevin's PhD research resulted in several peer reviewed publications in journals including Sensors and Actuators B: Chemical , the Analyst and the International Journal of Environmental Analytical Chemistry , as well as presentations at number of international conferences.
Kevin is presently working as an experienced researcher in the NASCENT Network, based at Queen Mary University of London. Over the next two years he will focus on the synthesis of functionalised monomers and their use in the preparation of molecularly imprinted polymeric materials.
Contact details:
School of Biological and Chemical Sciences
Walter Besant Building
Queen Mary, University of London
Mile End Road
London E1 4NS
UK
